Submitted a #careinnovation to @CMSinnovates: demonstrating how GoToPills identifies off-label medications during the claims process resulting in substantial savings for third-party payers and healthcare providers.
Walgreens is your top go to place, that’s why we are excited about the newest Rx Refill Transfer API integration by @GoToPills. Learn more: https://t.co/r3jfpvdhlj #RXAPI
New studies show increased risk of serious heart-related events such as heart attack or stroke, cancer, blood clots, and death with the arthritis and ulcerative colitis medicines Xeljanz and Xeljanz XR and arthritis medications Olumiant and Rinvoq.
The FDA fast tracked approval of the Alzheimer’s drug aducanumab (brand name Aduhelm) leading to two FDA advisors to quit in protest citing inconclusive evidence that the drug was effective.
The FDA approved the antiviral drug Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19. https://t.co/Q65vNuxRtc
@BillWhitakerCBS@60Minutes Great segment on the dangers of off-label medications. Hopefully consumers will become more aware of what off-label means and that there is no requirement that patients be informed their medication has not been tested for safety or efficacy for the prescribed indication.
Do not be fooled, the anti-malaria drug Hydroxychloroquine (Plaquenil) has dangerous side effects including congestive heart failure and death!
https://t.co/3Nkfye45yE
Today in contaminated Zantac news, a pharma company that makes generic Zantac for Walgreens, Walmart and Rite Aid in the US recalls its pills on carcinogen concerns
Meanwhile, France has recalled all versions of Zantac available in pharmacies
https://t.co/Cj8J4M7XCN
FDA issued new warning today about increased risk of blood clots and death with the 10 mg twice daily dose of tofacitinib (Xeljanz, Xeljanz XR), for ulcerative colitis.
Joining the suite of off-label prescribing tools for clinicians and off-label apps for consumers, GoToPills is adding an insurance alert feature so you will know if your medication is covered under the new 2020 indication-based prescribing options.
Zach Hansen our CTO is amazing! he just added a GoToPills Enterprise Solutions video that showcases how GoToPills reduces off-label medication risk and increases patient safety a must see https://t.co/tcUttCzoOa via @YouTube
Trial starts today in OK for over 10 billion dollars in damages against Johnson & Johnson for public nuisance and off-label marketing of opioids #opioidjustice
Newly unsealed docs in a federal case reveal drug company pushed off-label uses for Acthar Gel (a drug for infant seizure disorder), raised prices from $40/vial to $39,000/vial, and bribed physicians and office staff to push drug sales.
https://t.co/zgJO6ygkwc?